EUVIMEDEUVIMED entdecken
Fallbericht

CAR+ T-Cell Lymphoma after Cilta-cel Therapy for Relapsed or Refractory Myeloma

Simon J Harrison iD, Cyrille Touzeau, Nicolas Kint, Katherine Li, Tamia Nguyen, Caroline Mayeur-Rousse, Marzia Rahman, Yannick Le Bris, Jeremy Er, Juliette Eugene-Lamer, Nicole M Haynes, Jessica Li und 33 weitere

New England Journal of Medicine · 13.02.2025 · 392 (7) · 677-685

DOI: 10.1056/nejmoa2309728 ↗

Kurz gefasst

Fallbericht in der Zeitschrift New England Journal of Medicine, erschienen am 13.02.2025. Verfasst von Simon J Harrison und 44 weiteren Autor:innen. Beteiligte Einrichtung: Peter MacCallum Cancer Centre, Melbourne, VIC, Australia. Hauptthemen laut MEDLINE: Immunotherapy, Adoptive, Multiple Myeloma, Receptors, Chimeric Antigen, B-Cell Maturation Antigen. Die Arbeit wurde bisher 76-mal zitiert (Crossref) und nennt 24 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immunotherapy, AdoptiveMultiple MyelomaReceptors, Chimeric AntigenB-Cell Maturation AntigenLymphoma, T-Cell, PeripheralFemaleHumansMaleMiddle AgedRecurrenceT-LymphocytesClinical Trials, Phase III as TopicRandomized Controlled Trials as TopicMulticenter Studies as TopicMutagenesis, InsertionalBiopsyFace

Substanzen

Receptors, Chimeric AntigenTNFRSF17 protein, humanB-Cell Maturation Antigen

Autor:innen und Institutionen

  • Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
  • Royal Melbourne Hospital, Melbourne, VIC, Australia.
  • Translation Laboratory, Centre of Excellence in Cellular Immunotherapy, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
  • Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC, Australia.
  • Service d'Hématologie, Centre Hospitalier Universitaire (CHU) Hôtel Dieu, Nantes, France.
  • Centre de Recherche en Cancérologie et Immunologie Intégrée Nantes Angers, INSERM, Centre National de la Recherche Scientifique, Université d'Angers, Université de Nantes, Nantes, France.

ORCID-Profile: Simon J Harrison, Ing Soo Tiong

Zitieren

APA

Harrison, S. J., Touzeau, C., Kint, N., Li, K., Nguyen, T., Mayeur-Rousse, C., Rahman, M., Le Bris, Y., Er, J., Eugene-Lamer, J., Haynes, N. M., Li, J., Abbott, R. C., Bodet-Milin, C., Moreau, A., Letouzé, E., Lendvai, N., Schecter, J. M., Deraedt, W., …, & Blombery, P. (2025). CAR+ T-Cell Lymphoma after Cilta-cel Therapy for Relapsed or Refractory Myeloma. New England Journal of Medicine, 392(7), 677-685. https://doi.org/10.1056/nejmoa2309728

Vancouver

Harrison SJ, Touzeau C, Kint N, Li K, Nguyen T, Mayeur-Rousse C, et al. CAR+ T-Cell Lymphoma after Cilta-cel Therapy for Relapsed or Refractory Myeloma. New England Journal of Medicine. 2025;392(7):677-685. doi:10.1056/nejmoa2309728

BibTeX
@article{Harrison2025,
  author = {Harrison, Simon J and Touzeau, Cyrille and Kint, Nicolas and Li, Katherine and Nguyen, Tamia and Mayeur-Rousse, Caroline and Rahman, Marzia and Le Bris, Yannick and Er, Jeremy and Eugene-Lamer, Juliette and Haynes, Nicole M and Li, Jessica and Abbott, Rebecca C and Bodet-Milin, Caroline and Moreau, Anne and Letouzé, Eric and Lendvai, Nikoletta and Schecter, Jordan M and Deraedt, William and Banerjee, Arnob and Lengil, Tamar and Vogel, Martin and Foulk, Brad and Zhao, Hao and Smirnov, Denis and Slaughter, Ana and Lonardi, Carolina and Lee, Erin and Marquez, Loreta and Sankari, Ayah and Plaks, Vicki and Filho, Jose Octavio Costa and Patel, Nitin and Geng, Dong and Gastinne, Thomas and Kelly, Hannah and Tiong, Ing Soo and Eveillard, Marion and Chevallier, Patrice and Lade, Stephen and Moreau, Philippe and Grimmond, Sean and Oliaro, Jane and Tessoulin, Benoit and Blombery, Piers},
  title = {CAR+ T-Cell Lymphoma after Cilta-cel Therapy for Relapsed or Refractory Myeloma},
  journal = {New England Journal of Medicine},
  year = {2025},
  volume = {392},
  number = {7},
  pages = {677--685},
  doi = {10.1056/nejmoa2309728}
}
Kostenlos starten →